ProPhase Labs PRPH
OTC PRPH
$0.01 0.00 (-9.47%)
As of: Oct 23, 2026 · 11:54 AM EDT

ProPhase Labs (PRPH) Selling, General & Administrative (2010 - 2026)

Updated

ProPhase Labs' Selling, General & Administrative was $2.87 million in Q2 2026, down 37.9% from $4.62 million a year earlier but up 5.5% from the prior quarter.

Analysis

ProPhase Labs (PRPH) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, ProPhase Labs' Selling, General & Administrative was $16.2 million through Jun 30, 2026, down 50.0% year-over-year; for FY2025, it came in at $19.32 million, down 49.0% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 20.8% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $37.89 million in FY2024 (+13.3%), $33.44 million in FY2023 (-2.7%), $34.39 million in FY2022 (+52.9%) and $22.49 million in FY2021 (+200.0%).
  • Quarterly Selling, General & Administrative has moved between $2.72 million (Q1 2026) and $17.08 million (Q4 2024) over five years.
  • Compared with a year earlier, Selling, General & Administrative has declined for six straight quarters, with an average decline of 14.8% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 282.6%); the worst was Q4 2025 (a decline of 65.0%).
  • Per Business Quant data, PRPH's Selling, General & Administrative in the three quarters before Q2 2026 was $2.72 million (Q1 2026), $5.97 million (Q4 2025) and $4.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 6.29 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.63 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 5.65 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.92 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 3.41 Bn
10 ProPhase Labs 120,537.60 -425,462.40 226,000.00 2.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.87 Mn
Mar 31, 2026 2.72 Mn
Dec 31, 2025 5.97 Mn
Sep 30, 2025 4.64 Mn
Jun 30, 2025 4.62 Mn
Mar 31, 2025 4.09 Mn
Dec 31, 2024 17.08 Mn
Sep 30, 2024 6.57 Mn
Jun 30, 2024 6.93 Mn
Mar 31, 2024 7.30 Mn
Dec 31, 2023 6.96 Mn
Sep 30, 2023 8.25 Mn
Jun 30, 2023 9.94 Mn
Mar 31, 2023 8.30 Mn
Dec 31, 2022 12.74 Mn
Sep 30, 2022 7.51 Mn
Jun 30, 2022 6.31 Mn
Mar 31, 2022 7.82 Mn
Dec 31, 2021 7.78 Mn
Sep 30, 2021 5.94 Mn
API Access

ProPhase Labs Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=PRPH&period=max&api_key=YOUR_API_KEY